Antibiotic cement spacer retention for chronic shoulder infection after minimum 2-year follow-up

J Shoulder Elbow Surg. 2020 Sep;29(9):e325-e329. doi: 10.1016/j.jse.2020.01.065. Epub 2020 Mar 31.

Abstract

Hypothesis: The treatment of periprosthetic shoulder infections and proximal humerus osteomyelitis is challenging. The outcomes of antibiotic cement spacer retention are poorly defined in the literature. The purpose of this study was to review long-term functional and patient-reported outcomes data of patients with retained antibiotic cement spacers. We predict reasonable functional outcomes and minimal pain.

Methods: We identified 22 patients of the senior author who have been treated with definitive antibiotic spacer placement. All patients were originally offered a 2-stage revision and declined. Twelve patients had a minimum follow-up of 2 years and were included in our cohort. Mean age was 70.7 (range 59-81), 8/12 patients were female, and the average body mass index was 27.8 (range = 17-45). Functional outcome assessments included the Standardized Shoulder Assessment Form, the Quick Disabilities of the Arm, Shoulder, and Hand Score (QuickDASH), and visual analog scale (VAS) along with clinical range of motion examination.

Results: The patients were followed up for a mean of 5.6 years. Eight patients had spacer placement for chronic shoulder arthroplasty infections, whereas 4 patients had spacer placement for chronic osteomyelitis of the proximal humerus. No patients were currently being treated with suppressive antibiotics. One patient had negative cultures at the time of antibiotic spacer placement. The most common organisms were Cutibacterium acnes (6), Staphylococcus epidermidis (6), and methicillin-resistant Staphylococcus aureus (4), with 4 patients growing more than 1 species. The average ASES score was 54 (range = 27-73), QuickDASH was 45 (range = 14-89), and VAS score 2.8 (range = 0-8). Average active range of motion was 68° of forward elevation and 35° of external rotation.

Conclusions: Retention of antibiotic cement spacer is a viable option in the treatment algorithm for chronic shoulder infections. Long-term antibiotic cement spacer may be considered for those patients who are unwilling or unable to undergo a 2-stage revision. Patients can expect a reasonable amount of function and little to no pain with an antibiotic cement spacer.

Keywords: Shoulder arthroplasty; antibiotic spacer; infection; osteomyelitis; reverse total shoulder arthroplasty; revision arthroplasty; total shoulder arthroplasty.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use*
  • Arthroplasty / adverse effects*
  • Bone Cements / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Middle Aged
  • Osteoarthritis / surgery
  • Osteomyelitis / surgery
  • Propionibacteriaceae / isolation & purification*
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology*
  • Range of Motion, Articular
  • Retrospective Studies
  • Shoulder / surgery*
  • Shoulder Joint / surgery*
  • Staphylococcus epidermidis / isolation & purification*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Bone Cements

Supplementary concepts

  • Cutibacterium acnes subsp. acnes